Biofire Defense recalls
2 notices naming Biofire Defense as the recalling firm, since October 1, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Biofire Defense: FilmArray NGDS Warrior Panel REF NGDS-ASY-0007 UDI-DI code:
Hazard (FDA): Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test.
FDAMedical devices
Biofire Defense: FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative
Hazard (FDA): FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.
FDAMedical devices